Diabetes is a national healthcare crisis related to both macrovascular and microvascular
complications. We hypothesized that higher levels of physical activity are associated
with lower total and visceral fat mass, lower systolic blood pressure, and increased
insulin sensitivity. Participant inclusion criteria: 21-50 years old, BMI ≥ 30 kg/m2,
hemoglobin A1C 5.7-6.4, fasting glucose 100-125 mg/dL, and HOMA IR ≥ 2.5. Exclusion
criteria: history of diabetes, hypertension, HIV, renal disease, hearing loss, alcoholic
intake over four drinks daily, use of organic nitrates or PDE5 inhibitors, and decreased
cardiac function. Total physical activity was measured using accelerometers, body
composition using DXA, and insulin resistance via fsIVGTT. Clinical and biochemical
cardiometabolic risk factors, blood pressure and heart rate obtained using a calibrated
sphygmomanometer. Anthropometric measures, fasting glucose, insulin, lipid profile,
C-reactive protein, and BMP analyzed using standard procedures. Within our study,
we found correlations between levels of physical activity in a heterogenous group
of prediabetic adults. Patients with more physical activity had a higher degree of
insulin sensitivity, lower blood pressure, total visceral adipose tissue, and overall
lower total mass. Total physical activity levels showed small, but significant correlations
with systolic blood pressure, visceral fat, lean mass and insulin sensitivity. After
normalizing for race, age, and gender using multiple regression, these associations
were no longer significant considering our small sample size. More research into prediabetes
will decrease the population of diabetics overall. In the future we could increase
sample size and conduct cross sectional and longitudinal studies in various populations
with prediabetes.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Metabolism - Clinical and ExperimentalAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect